Friday, May 22, 2015 12:24:04 PM
that the alleged FINRA assertion of reinstatement based on form 10 filing, alone,
was just BS?
imo, FINRA's decision will be based on whether they feel Mark has changed his stripes
and will be focusing on building actual fiscal value into MIKP
rather than just using it as an ATM for failed media biz ventures.
filing the audited form 10 was a big step forward in professionalism.
but i suspect FINRA would be more impressed if Mark had made tangible progress on any of the lingering film projects.
WS still in post limbo...
ST still in "development" but obviously blowing financing deals, per lawsuit discussed here earlier...
the only tangible product Mark has brought to market is the graphic novel.
and that project was driven primarily by Colucci.
there's still hope here.
but, imo, the likelihood of FINRA reinstatement would be higher if Mark had made tangible progress on the film front over the past 3 years.
99.99% of all pinks are scams. Best to assume the other 0.01% are as well.
Recent MIKP News
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 11/28/2023 10:00:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/22/2023 06:06:28 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 07:00:35 PM
- Form PREM14C - Preliminary information statements relating to merger or acquisition • Edgar (US Regulatory) • 11/02/2023 04:01:43 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 10/04/2023 04:01:33 PM
- Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 08/23/2023 08:54:45 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/22/2023 06:10:15 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 01:07:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/28/2023 01:43:32 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM